Effect of rebamipide, a novel antiulcer agent, on helicobacter pylori adhesion to gastric epithelial cells

Shunji Hayashi, Toshiro Sugiyama, Ken Ichi Amano, Hiroshi Isogai, Emiko Isogai, Miki Aihara, Mikio Kikuchi, Masahiro Asaka, Kenji Yokota, Keiji Oguma, Nobuhiro Fujii, Yoshikazu Hirai

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Helicobacter pylori is a major etiological agent in gastroduodenal disorders. The adhesion of H. pylori to human gastric epithelial cells is the initial step of H. pylori infection. Inhibition of H. pylori adhesion is thus a therapeutic target in the prevention of H. pylori infection. Experiments were performed to evaluate the effect of rebamipide, a novel antiulcer agent, on H. pylori adhesion to gastric epithelial cells. MKN-28 and MKN-45 cells, derived from human gastric carcinomas, were used as target cells. Ten H. pylori strains isolated from patients with chronic gastritis and gastric ulcer were used in the study. We evaluated the effect of rebamipide on H. pylori adhesion to MKN-28 and MKN-45 cells quantitatively using our previously established enzyme-linked immunosorbent assay. The adhesion of H. pylori to MKN-28 and MKN-45 cells was significantly inhibited by pretreatment of these cells with 100 μg of rebamipide per ml. However, the adhesion was not affected by the pretreatment of H. pylori with rebamipide. On the other hand, the viabilities of H. pylori, MKN-28 cells, and MKN-45 cells were not affected by rebamipide. Our studies suggest that rebamipide inhibits the adhesion of H. pylori to gastric epithelial cells.

Original languageEnglish
Pages (from-to)1895-1899
Number of pages5
JournalAntimicrobial Agents and Chemotherapy
Volume42
Issue number8
Publication statusPublished - Aug 1998

Fingerprint

Helicobacter pylori
Stomach
Epithelial Cells
Helicobacter Infections
rebamipide
Gastritis
Stomach Ulcer
Enzyme-Linked Immunosorbent Assay
Carcinoma

ASJC Scopus subject areas

  • Pharmacology (medical)

Cite this

Hayashi, S., Sugiyama, T., Amano, K. I., Isogai, H., Isogai, E., Aihara, M., ... Hirai, Y. (1998). Effect of rebamipide, a novel antiulcer agent, on helicobacter pylori adhesion to gastric epithelial cells. Antimicrobial Agents and Chemotherapy, 42(8), 1895-1899.

Effect of rebamipide, a novel antiulcer agent, on helicobacter pylori adhesion to gastric epithelial cells. / Hayashi, Shunji; Sugiyama, Toshiro; Amano, Ken Ichi; Isogai, Hiroshi; Isogai, Emiko; Aihara, Miki; Kikuchi, Mikio; Asaka, Masahiro; Yokota, Kenji; Oguma, Keiji; Fujii, Nobuhiro; Hirai, Yoshikazu.

In: Antimicrobial Agents and Chemotherapy, Vol. 42, No. 8, 08.1998, p. 1895-1899.

Research output: Contribution to journalArticle

Hayashi, S, Sugiyama, T, Amano, KI, Isogai, H, Isogai, E, Aihara, M, Kikuchi, M, Asaka, M, Yokota, K, Oguma, K, Fujii, N & Hirai, Y 1998, 'Effect of rebamipide, a novel antiulcer agent, on helicobacter pylori adhesion to gastric epithelial cells', Antimicrobial Agents and Chemotherapy, vol. 42, no. 8, pp. 1895-1899.
Hayashi S, Sugiyama T, Amano KI, Isogai H, Isogai E, Aihara M et al. Effect of rebamipide, a novel antiulcer agent, on helicobacter pylori adhesion to gastric epithelial cells. Antimicrobial Agents and Chemotherapy. 1998 Aug;42(8):1895-1899.
Hayashi, Shunji ; Sugiyama, Toshiro ; Amano, Ken Ichi ; Isogai, Hiroshi ; Isogai, Emiko ; Aihara, Miki ; Kikuchi, Mikio ; Asaka, Masahiro ; Yokota, Kenji ; Oguma, Keiji ; Fujii, Nobuhiro ; Hirai, Yoshikazu. / Effect of rebamipide, a novel antiulcer agent, on helicobacter pylori adhesion to gastric epithelial cells. In: Antimicrobial Agents and Chemotherapy. 1998 ; Vol. 42, No. 8. pp. 1895-1899.
@article{ceb51ce634b045e2958d366b98c07054,
title = "Effect of rebamipide, a novel antiulcer agent, on helicobacter pylori adhesion to gastric epithelial cells",
abstract = "Helicobacter pylori is a major etiological agent in gastroduodenal disorders. The adhesion of H. pylori to human gastric epithelial cells is the initial step of H. pylori infection. Inhibition of H. pylori adhesion is thus a therapeutic target in the prevention of H. pylori infection. Experiments were performed to evaluate the effect of rebamipide, a novel antiulcer agent, on H. pylori adhesion to gastric epithelial cells. MKN-28 and MKN-45 cells, derived from human gastric carcinomas, were used as target cells. Ten H. pylori strains isolated from patients with chronic gastritis and gastric ulcer were used in the study. We evaluated the effect of rebamipide on H. pylori adhesion to MKN-28 and MKN-45 cells quantitatively using our previously established enzyme-linked immunosorbent assay. The adhesion of H. pylori to MKN-28 and MKN-45 cells was significantly inhibited by pretreatment of these cells with 100 μg of rebamipide per ml. However, the adhesion was not affected by the pretreatment of H. pylori with rebamipide. On the other hand, the viabilities of H. pylori, MKN-28 cells, and MKN-45 cells were not affected by rebamipide. Our studies suggest that rebamipide inhibits the adhesion of H. pylori to gastric epithelial cells.",
author = "Shunji Hayashi and Toshiro Sugiyama and Amano, {Ken Ichi} and Hiroshi Isogai and Emiko Isogai and Miki Aihara and Mikio Kikuchi and Masahiro Asaka and Kenji Yokota and Keiji Oguma and Nobuhiro Fujii and Yoshikazu Hirai",
year = "1998",
month = "8",
language = "English",
volume = "42",
pages = "1895--1899",
journal = "Antimicrobial Agents and Chemotherapy",
issn = "0066-4804",
publisher = "American Society for Microbiology",
number = "8",

}

TY - JOUR

T1 - Effect of rebamipide, a novel antiulcer agent, on helicobacter pylori adhesion to gastric epithelial cells

AU - Hayashi, Shunji

AU - Sugiyama, Toshiro

AU - Amano, Ken Ichi

AU - Isogai, Hiroshi

AU - Isogai, Emiko

AU - Aihara, Miki

AU - Kikuchi, Mikio

AU - Asaka, Masahiro

AU - Yokota, Kenji

AU - Oguma, Keiji

AU - Fujii, Nobuhiro

AU - Hirai, Yoshikazu

PY - 1998/8

Y1 - 1998/8

N2 - Helicobacter pylori is a major etiological agent in gastroduodenal disorders. The adhesion of H. pylori to human gastric epithelial cells is the initial step of H. pylori infection. Inhibition of H. pylori adhesion is thus a therapeutic target in the prevention of H. pylori infection. Experiments were performed to evaluate the effect of rebamipide, a novel antiulcer agent, on H. pylori adhesion to gastric epithelial cells. MKN-28 and MKN-45 cells, derived from human gastric carcinomas, were used as target cells. Ten H. pylori strains isolated from patients with chronic gastritis and gastric ulcer were used in the study. We evaluated the effect of rebamipide on H. pylori adhesion to MKN-28 and MKN-45 cells quantitatively using our previously established enzyme-linked immunosorbent assay. The adhesion of H. pylori to MKN-28 and MKN-45 cells was significantly inhibited by pretreatment of these cells with 100 μg of rebamipide per ml. However, the adhesion was not affected by the pretreatment of H. pylori with rebamipide. On the other hand, the viabilities of H. pylori, MKN-28 cells, and MKN-45 cells were not affected by rebamipide. Our studies suggest that rebamipide inhibits the adhesion of H. pylori to gastric epithelial cells.

AB - Helicobacter pylori is a major etiological agent in gastroduodenal disorders. The adhesion of H. pylori to human gastric epithelial cells is the initial step of H. pylori infection. Inhibition of H. pylori adhesion is thus a therapeutic target in the prevention of H. pylori infection. Experiments were performed to evaluate the effect of rebamipide, a novel antiulcer agent, on H. pylori adhesion to gastric epithelial cells. MKN-28 and MKN-45 cells, derived from human gastric carcinomas, were used as target cells. Ten H. pylori strains isolated from patients with chronic gastritis and gastric ulcer were used in the study. We evaluated the effect of rebamipide on H. pylori adhesion to MKN-28 and MKN-45 cells quantitatively using our previously established enzyme-linked immunosorbent assay. The adhesion of H. pylori to MKN-28 and MKN-45 cells was significantly inhibited by pretreatment of these cells with 100 μg of rebamipide per ml. However, the adhesion was not affected by the pretreatment of H. pylori with rebamipide. On the other hand, the viabilities of H. pylori, MKN-28 cells, and MKN-45 cells were not affected by rebamipide. Our studies suggest that rebamipide inhibits the adhesion of H. pylori to gastric epithelial cells.

UR - http://www.scopus.com/inward/record.url?scp=0031927584&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031927584&partnerID=8YFLogxK

M3 - Article

C2 - 9687380

AN - SCOPUS:0031927584

VL - 42

SP - 1895

EP - 1899

JO - Antimicrobial Agents and Chemotherapy

JF - Antimicrobial Agents and Chemotherapy

SN - 0066-4804

IS - 8

ER -